Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

JNK as a novel therapeutic target in cholestatic liver diseases

Sep. 8, 2020

MOSPD2 found as a therapeutic target for treating NASH

Sep. 7, 2020

Increased expression of MUDENG linked to accelerated liver fibrosis in mice

Sep. 4, 2020

Abivax reports 2-year data from phase IIa maintenance study of ABX-464 in ulcerative colitis

Sep. 3, 2020

First-in-human data presented for TQA-3526

Sep. 3, 2020

Poxel opens phase II trial of PXL-065 for noncirrhotic biopsy-proven NASH

Sep. 2, 2020

Results from first clinical trial of KB-174 in patients with well-compensated cirrhosis

Sep. 1, 2020

Data presented on PF-05221304 and PF-06865571 coadministration in NAFLD patients

Aug. 31, 2020

New phase IIa study evaluates AMT-101 in ulcerative colitis

Aug. 28, 2020

Albireo presents new SLC10A2 and/or SLC10A1 inhibitors

Aug. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....